Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.
about
Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.What Have We Learnt about BCG Vaccination in the Last 20 Years?The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing.Polyfunctional CD4+ T Cells As Targets for Tuberculosis VaccinationMolecular Signatures of Immunity and Immunogenicity in Infection and Vaccination.The current status, challenges, and future developments of new tuberculosis vaccines.Neonatal Immunization: Rationale, Current State, and Future Prospects.Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.Development of New Preventive and Therapeutic Vaccines for Tuberculosis.
P2860
Q39294350-7F1C24B3-7019-4476-8FFC-0AFF479D81E2Q40109570-2D373183-E6F9-4B76-B135-386154A91765Q40116835-840954F9-4D29-441E-A899-775B1B38D227Q41684091-A8D68FE6-8767-41EA-84DE-920CF477A563Q41836016-BA384D4D-67C2-4FF5-9A92-E59363352A35Q42373425-8EF73945-76F3-41A3-B678-C3FAB9A9F580Q47142985-ADE703DB-B1BC-4AC3-B5A7-05FB7F5948F8Q52337140-C797F749-27C2-4E7E-BCC5-BC27A037AAF2Q52579157-C1088588-1486-427F-BE3C-E20A51EE188FQ52657152-2F0C7D07-75C0-43E2-BEE5-8D89E21415CCQ55280574-841327ED-598E-4D14-ACB5-47D10CF8A185
P2860
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@en
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@nl
type
label
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@en
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@nl
prefLabel
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@en
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@nl
P2093
P2860
P50
P356
P1476
Safety and Immunogenicity of t ...... wborn Infants in South Africa.
@en
P2093
Andrea Gutschmidt
Anneke C Hesseling
Bernd Eisele
Christiane Meller
Hilary Johnstone
Jeroen Maertzdorf
Julia K Knaul
Leander Grode
Mark F Cotton
Stefan H E Kaufmann
P2860
P356
10.1128/CVI.00439-16
P577
2016-12-14T00:00:00Z